Entropy Neurodynamics Limited has released a press release.
Market Update
Filed with ASX ·
On 6ix: 6ix.com/news/market-update-299
6ix hasn’t read this filing yet.
Entropy Neurodynamics Limited on 6ix
Earlier from Entropy Neurodynamics
- Explainer The critical bottleneck of exosome isolation
- Appendix 4D and Interim Financial Report - Dec 18 Half Year
- Positive outcomes in first animal study involving Plexaris
- December 2018 Quarterly Cash Flow Report
- December 2018 Quarterly Activities Report
Later from Entropy Neurodynamics
- Securures Ethics Approval for Plexoval Clinical Trial
- Share Placement and Share Purchase Plan Announced
- Share Purchase Plan 2019 Offer Document
- PLEXOVAL Exosome Wound Healing Human Study Starts
- Appendix 4E and Annual Financial Report FY 2019
Follow Entropy Neurodynamics into a list and get an email when it puts out news.
Follow Entropy Neurodynamics